# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-333831
Filing Date
2026-08-05
Accepted
2026-08-05 07:09:35
Documents
86
Period of Report
2026-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | qttb-20260630.htm iXBRL | 10-Q | 2555334
2 | EX-31.1 | qttb-ex31_1.htm | EX-31.1 | 15713
3 | EX-31.2 | qttb-ex31_2.htm | EX-31.2 | 15708
4 | EX-32.1 | qttb-ex32_1.htm | EX-32.1 | 9783
5 | EX-32.2 | qttb-ex32_2.htm | EX-32.2 | 9778
| Complete submission text file | 0001193125-26-333831.txt |  | 10955623

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | qttb-20260630.xsd | EX-101.SCH | 1792662
90 | EXTRACTED XBRL INSTANCE DOCUMENT | qttb-20260630_htm.xml | XML | 1771844

Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Filer) CIK: 0001661998 (see all company filings)

EIN.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38433 | Film No.: 261241315
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)